Michael K. Kießling

2.8k total citations · 1 hit paper
25 papers, 2.3k citations indexed

About

Michael K. Kießling is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Michael K. Kießling has authored 25 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Immunology. Recurrent topics in Michael K. Kießling's work include Melanoma and MAPK Pathways (6 papers), T-cell and Retrovirus Studies (3 papers) and Cutaneous lymphoproliferative disorders research (3 papers). Michael K. Kießling is often cited by papers focused on Melanoma and MAPK Pathways (6 papers), T-cell and Retrovirus Studies (3 papers) and Cutaneous lymphoproliferative disorders research (3 papers). Michael K. Kießling collaborates with scholars based in Switzerland, Germany and United States. Michael K. Kießling's co-authors include Christopher M. Owens, Matthew Stremlau, Patrick Autissier, Joseph Sodroski, Michel Perron, Peter H. Krammer, Karsten Gülow, Marcin M. Kamiński, Dorothee Süss and Ioanna E. Galani and has published in prestigious journals such as Nature, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Michael K. Kießling

24 papers receiving 2.3k citations

Hit Papers

The cytoplasmic body comp... 2004 2026 2011 2018 2004 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
    2004 1.5k citations Matthew Stremlau, Christopher M. Owens et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael K. Kießling Switzerland 14 1.1k 993 854 589 398 25 2.3k
Andrew J. Henderson United States 29 1.1k 1.0× 1.1k 1.1× 855 1.0× 334 0.6× 592 1.5× 73 2.4k
Caili Hao United States 16 1.1k 1.1× 796 0.8× 872 1.0× 475 0.8× 461 1.2× 26 2.0k
Ling‐Jun Zhao United States 23 701 0.6× 480 0.5× 971 1.1× 269 0.5× 439 1.1× 62 1.9k
Andreas S. Baur Germany 29 1.9k 1.8× 1.3k 1.3× 1.3k 1.5× 433 0.7× 923 2.3× 61 3.3k
Zhiyuan Yang China 16 936 0.9× 875 0.9× 2.5k 2.9× 335 0.6× 506 1.3× 57 3.6k
T. Jesse Kwoh United States 22 660 0.6× 380 0.4× 1.3k 1.6× 426 0.7× 404 1.0× 41 2.4k
Gregory A. Viglianti United States 24 550 0.5× 1.9k 1.9× 813 1.0× 337 0.6× 287 0.7× 42 3.0k
Andrew N. Harman Australia 26 846 0.8× 1.3k 1.3× 500 0.6× 545 0.9× 334 0.8× 52 2.1k
Samuel A. Williams United States 15 973 0.9× 642 0.6× 881 1.0× 269 0.5× 592 1.5× 20 2.0k
Catherine Transy France 27 938 0.9× 1.2k 1.2× 1.4k 1.6× 838 1.4× 438 1.1× 49 3.1k

Countries citing papers authored by Michael K. Kießling

Since Specialization
Citations

This map shows the geographic impact of Michael K. Kießling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael K. Kießling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael K. Kießling more than expected).

Fields of papers citing papers by Michael K. Kießling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael K. Kießling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael K. Kießling. The network helps show where Michael K. Kießling may publish in the future.

Co-authorship network of co-authors of Michael K. Kießling

This figure shows the co-authorship network connecting the top 25 collaborators of Michael K. Kießling. A scholar is included among the top collaborators of Michael K. Kießling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael K. Kießling. Michael K. Kießling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pradervand, Sylvain, Rita Achermann, Simon Haefliger, et al.. (2024). Real-world occurrence, therapy, and outcome of patients with class 2 or 3 BRAF compared with class 1 BRAF-mutated cancers. SHILAP Revista de lepidopterología. 6. 100075–100075. 1 indexed citations
2.
3.
4.
Trojan, Andreas, Michael K. Kießling, Meinrad Mannhart, et al.. (2024). Towards an early warning system for monitoring of cancer patients using hybrid interactive machine learning. Frontiers in Digital Health. 6. 1443987–1443987. 2 indexed citations
5.
Jetter, Alexander, et al.. (2023). Interference of Herbal Medicine with Axitinib in Metastatic Renal Cell Cancer Treatment: A Case Study. SHILAP Revista de lepidopterología. 16(1). 1362–1369.
6.
Goldman, Jean-Philippe, Rita Achermann, Julien Gobeill, et al.. (2023). Multilingual RECIST classification of radiology reports using supervised learning. Frontiers in Digital Health. 5. 1195017–1195017. 2 indexed citations
7.
Akhoundova, Dilara, Martina Haberecker, Ralph Fritsch, et al.. (2022). Targeting ALK in Neuroendocrine Tumors of the Lung. Frontiers in Oncology. 12. 911294–911294. 16 indexed citations
8.
Gannon, Hugh, Tao Zou, Michael K. Kießling, et al.. (2018). Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells. Nature Communications. 9(1). 5450–5450. 159 indexed citations
9.
Kießling, Michael K., Sven Schuierer, Silke Stertz, et al.. (2016). Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening. BMC Genomics. 17(1). 723–723. 31 indexed citations
10.
Kießling, Michael K., Alessandra Curioni‐Fontecedro, Panagiotis Samaras, et al.. (2016). Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma. PLoS ONE. 11(1). e0147682–e0147682. 29 indexed citations
11.
Maul, Julia‐Tatjana, Frank Stenner, Burkhardt Seifert, et al.. (2016). Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo‐mobilization with vinorelbine in multiple myeloma patients. Journal of Clinical Apheresis. 32(1). 21–26. 8 indexed citations
12.
Kießling, Michael K., et al.. (2015). Mutant HRAS as novel target for MEK and mTOR inhibitors.. Journal of Clinical Oncology. 33(15_suppl). 11082–11082. 3 indexed citations
13.
Kießling, Michael K. & Gerhard Rogler. (2015). Targeting the RAS pathway by mitogen-activated protein kinase inhibitors. Swiss Medical Weekly. 145(5152). w14207–w14207. 12 indexed citations
14.
Grün, Barbara, Michael K. Kießling, Jürgen Burhenne, et al.. (2013). Trimethoprim–metformin interaction and its genetic modulation by OCT2 and MATE1 transporters. British Journal of Clinical Pharmacology. 76(5). 787–796. 65 indexed citations
15.
Möck, Thomas, Dorothee Nickles, Michael K. Kießling, et al.. (2012). A PP4 Holoenzyme Balances Physiological and Oncogenic Nuclear Factor-Kappa B Signaling in T Lymphocytes. Immunity. 37(4). 697–708. 48 indexed citations
16.
Kießling, Michael K., Patrick A. Oberholzer, Chandrani Mondal, et al.. (2011). High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade. Blood. 117(8). 2433–2440. 60 indexed citations
17.
Kießling, Michael K., et al.. (2009). Inhibition of Constitutively Activated Nuclear Factor-κB Induces Reactive Oxygen Species- and Iron-Dependent Cell Death in Cutaneous T-Cell Lymphoma. Cancer Research. 69(6). 2365–2374. 105 indexed citations
18.
Kamiński, Marcin M., Michael K. Kießling, Dorothee Süss, Peter H. Krammer, & Karsten Gülow. (2007). Novel Role for Mitochondria: Protein Kinase Cθ-Dependent Oxidative Signaling Organelles in Activation-Induced T-Cell Death. Molecular and Cellular Biology. 27(10). 3625–3639. 116 indexed citations
19.
Krammer, Peter H., Marcin M. Kamiński, Michael K. Kießling, & Karsten Gülow. (2007). No Life Without Death. Advances in cancer research. 97. 111–138. 26 indexed citations
20.
Stremlau, Matthew, Christopher M. Owens, Michel Perron, et al.. (2004). The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature. 427(6977). 848–853. 1496 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew J. Henderson Breakdown of academic impact, for papers by Caili Hao Breakdown of academic impact, for papers by Ling‐Jun Zhao Breakdown of academic impact, for papers by Andreas S. Baur Breakdown of academic impact, for papers by Zhiyuan Yang Breakdown of academic impact, for papers by T. Jesse Kwoh Breakdown of academic impact, for papers by Gregory A. Viglianti Breakdown of academic impact, for papers by Andrew N. Harman Breakdown of academic impact, for papers by Samuel A. Williams Breakdown of academic impact, for papers by Catherine Transy
Rankless by CCL
2026